meta
|
Preg
- medecines during pregnancy KB
Search
Calcium channel blockers (versus unexposed)
Overall results
Study description
Excluded studies
Table
Graphic
auto
during pregnancy (anytime or not specified)
1st trimester
2nd trimester
3rd trimester
2nd and/or 3rd trimester
throughout pregnancy
early pregnancy
days before delivery
late pregnancy
preconception-only
periconceptional
preconceptional for kinetic reason
at least 1st trimester
3 months (or more) before pregnancy or during pregnancy
1st and 2nd trimester
3 months or more before pregnancy or1st trimester
Whatever the period exposition
individual studies
Outcome
TE
95% CI
n cases
n exposed
k
Pub. bias
Congenital malformations
All congenital malformations (majors, minors, majors and minors, or unspecified)
Magee - Calcium blockers, 1996 Sorensen - Calcium blockers, 2001 Weber-Schoendorfer - Calcium blockers, 2008 Nakhai-Pour - Calcium blockers, 2010 Vasilakis-Scaramozza - Calcium blockers, 2013 Van Gelder - Calcium blockers, 2015 Mito - Amlodipine, 2019 Ishikawa - Amlodipine (Controls unexposed, sick), 2023
8
1.44
[
1.07
; 1.93]
32,739
570
not evaluable
Major congenital malformations
Magee - Calcium blockers, 1996 Sorensen - Calcium blockers, 2001 Weber-Schoendorfer - Calcium blockers, 2008 Nakhai-Pour - Calcium blockers, 2010 Vasilakis-Scaramozza - Calcium blockers, 2013 Van Gelder - Calcium blockers, 2015 Mito - Amlodipine, 2019 Ishikawa - Amlodipine (Controls unexposed, sick), 2023
8
1.48
[
1.09
; 2.02]
32,713
569
not evaluable
Congenital heart defects
Sorensen - Calcium blockers, 2001 Lennestal - Calcium inhibitors, 2009 Fisher - Calcium blockers (Controls unexposed, sick), 2017
3
1.42
[
0.87
; 2.30]
17,130
304
not evaluable
Hypospadias
Sorensen - Calcium blockers, 2001 Van Zutphen - Calcium blockers, 2014
2
1.29
[
0.61
; 2.71]
5,163
65
not evaluable
Atresia or stenosis of other parts of small intestine
Sorensen - Calcium blockers, 2001 Fisher a - Calcium blockers, 2018
2
9.17
[
3.26
; 25.75]
578
49
not evaluable
Atrial septal defect
Fisher - Calcium blockers (Controls unexposed, sick), 2017
1
2.18
[
0.73
; 6.51]
-
18
not evaluable
Genital anomalies
Vasilakis-Scaramozza - Calcium blockers, 2013
1
1.30
[
0.12
; 14.48]
5
55
not evaluable
Hypoplastic left heart (HLH/HLHS)
Fisher - Calcium blockers (Controls unexposed, sick), 2017
1
5.21
[
1.09
; 25.00]
-
14
not evaluable
Oesophageal atresia with or without tracheo-oesophageal fistula
Sorensen - Calcium blockers, 2001
1
1.83
[
0.11
; 29.79]
214
49
not evaluable
Pulmonary valve stenosis
Fisher - Calcium blockers (Controls unexposed, sick), 2017
1
1.99
[
0.52
; 7.66]
-
-
not evaluable
Ventricular septal defect
Fisher - Calcium blockers (Controls unexposed, sick), 2017
1
2.95
[
0.83
; 10.49]
-
-
not evaluable
Cleft lip with or without cleft palate
Sorensen - Calcium blockers, 2001
1
2.20
[
0.79
; 6.12]
1,368
53
not evaluable
Cleft palate
Sorensen - Calcium blockers, 2001
1
1.20
[
0.18
; 8.05]
596
50
not evaluable
Club foot / Talipes equinovarus
Sorensen - Calcium blockers, 2001
1
-
-
-
-
-
Coarctation of aorta
Caton - Calcium blockers, 2009
1
1.07
[
0.06
; 19.41]
406
6
not evaluable
Ear malformations
Sorensen - Calcium blockers, 2001
1
2.40
[
0.32
; 18.23]
351
50
not evaluable
Ebstein's anomaly
Caton - Calcium blockers, 2009
1
6.65
[
0.36
; 121.46]
65
6
not evaluable
Hydrocephaly
Sorensen - Calcium blockers, 2001
1
2.50
[
0.32
; 19.42]
311
50
not evaluable
Limb defects
Weber-Schoendorfer - Calcium blockers, 2008
1
2.12
[
0.35
; 12.79]
5
228
not evaluable
Limb reduction defects (LRD)
Sorensen - Calcium blockers, 2001
1
1.40
[
0.20
; 9.90]
545
50
not evaluable
Neural Tube Defects
Sorensen - Calcium blockers, 2001
1
2.10
[
0.63
; 6.96]
1,191
52
not evaluable
Polydactyly
Sorensen - Calcium blockers, 2001
1
0.50
[
0.08
; 3.08]
1,730
50
not evaluable
Growth parameters and prematurity
Preterm (< 37 weeks)
Magee - Calcium blockers, 1996 Weber-Schoendorfer - Calcium blockers, 2008 Su - Calcium blockers (Controls unexposed, sick), 2013 Mito - Amlodipine, 2019 Fitton - Calcium blockers (Controls unexposed, sick), 2020 Al Khalaf - Calcium channel blockers (Controls unexposed, sick), 2022 Vaclavik - Amlodipine, 2024
7
2.50
[
1.79
; 3.51]
1,809
1,188
not evaluable
Small for gestational age (weight)
Magee - Calcium blockers, 1996 Bayliss - Calcium blockers, 2002 Nakhai-Pour - Calcium blockers, 2010 Su - Calcium blockers (Controls unexposed, sick), 2013 Fisher b - Calcium inhibitors (Controls unexposed, sick), 2018 Fitton - Calcium blockers (Controls unexposed, sick), 2020 Al Khalaf - Calcium channel blockers (Controls unexposed, sick), 2022
7
1.32
[
0.93
; 1.86]
9,229
853
not evaluable
Low birth weight (< 2500g)
Su - Calcium blockers (Controls unexposed, sick), 2013 Mito - Amlodipine, 2019 Fitton - Calcium blockers (Controls unexposed, sick), 2020 Vaclavik - Amlodipine, 2024
4
1.56
[
0.80
; 3.03]
992
605
not evaluable
Very preterm (28 to 32 weeks)
Al Khalaf - Calcium channel blockers (Controls unexposed, sick), 2022
1
2.67
[
1.60
; 4.44]
220
256
not evaluable
Maternal consequences
Caesarean
Wide-Swensson - Isradipine, 1995 Darcie - Isradipine, 2004 Vaclavik - Amlodipine, 2024
3
2.35
[
1.51
; 3.68]
61
307
not evaluable
Preeclampsia
Bayliss - Calcium blockers, 2002 Mito - Amlodipine, 2019 Al Khalaf - Calcium channel blockers (Controls unexposed, sick), 2022
3
1.10
[
0.66
; 1.83]
1,004
351
not evaluable
Assisted deliveries (forceps, vacuum, ...)
Wide-Swensson - Isradipine, 1995 Darcie - Isradipine, 2004
2
1.90
[
0.46
; 7.85]
16
86
not evaluable
Gestational diabetes
Mito - Amlodipine, 2019
1
0.29
[
0.08
; 1.02]
27
48
not evaluable
Neonatal disorders
Neonatal medical care
Wide-Swensson - Isradipine, 1995
1
1.06
[
0.41
; 2.73]
23
46
not evaluable
Fetal distress
0
-
-
-
-
-
Low Apgar score (< 7) (at 5 min)
Darcie - Isradipine, 2004
1
0.35
[
0.01
; 18.56]
-
39
not evaluable
Jaundice / Icterus
Magee - Calcium blockers, 1996
1
0.45
[
0.10
; 2.02]
12
14
not evaluable
Low Apgar score (< 7) (at 1 min)
Darcie - Isradipine, 2004
1
0.50
[
0.07
; 3.36]
5
39
not evaluable
Low Apgar score (< 7) (NOS)
Vaclavik - Amlodipine, 2024
1
1.95
[
1.55
; 2.46]
-
88
not evaluable
Neonatal disorders (as a whole)
Magee - Calcium blockers, 1996
1
0.57
[
0.26
; 1.25]
40
51
not evaluable
Neonatal hypoglycemia
Darcie - Isradipine, 2004
1
4.00
[
1.06
; 15.08]
28
39
not evaluable
Very low Apgar score (< 5) (at 1 min)
Darcie - Isradipine, 2004
1
1.85
[
0.08
; 41.05]
2
39
not evaluable
Intrauterine deaths
Late intrauterine deaths (> 22 weeks)
Weber-Schoendorfer - Calcium blockers, 2008 Al Khalaf - Calcium channel blockers (Controls unexposed, sick), 2022
2
0.92
[
0.10
; 8.85]
84
2,220
not evaluable
Early intrauterine death (< 22 weeks)
Weber-Schoendorfer - Calcium blockers, 2008
1
2.21
[
1.39
; 3.51]
98
268
not evaluable
Intrauterine deaths (as a whole or unspecified)
Magee - Calcium blockers, 1996
1
2.13
[
0.89
; 5.10]
26
81
not evaluable
Therapeutic terminations of pregnancy
Magee - Calcium blockers, 1996
1
1.22
[
0.36
; 4.16]
11
81
not evaluable
Elective/induced termination of pregnancy
Weber-Schoendorfer - Calcium blockers, 2008
1
2.99
[
1.78
; 5.04]
61
299
not evaluable
Perinatal death
Magee - Calcium blockers, 1996
1
5.13
[
0.24
; 108.52]
2
81
not evaluable
0.0
100.0
1.0
